The weekly litigation news digest is live. Subscribe now

IP Verse

Method Of Modifying Eukaryotic Cells - EP3085779

The patent EP3085779 was granted to Regeneron Pharmaceuticals on May 31, 2023. The application was filed on Feb 15, 2002 under application number EP16171559A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3085779

REGENERON PHARMACEUTICALS
Application Number
EP16171559A
Filing Date
Feb 15, 2002
Status
Patent Maintained As Amended
Apr 28, 2023
Publication Date
May 31, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
KYMABApr 5, 2019CMS CAMERON MCKENNA NABARRO OLSWANGWITHDRAWN

Patent Citations (28) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5350689
DESCRIPTIONUS5436149
DESCRIPTIONUS5508189
DESCRIPTIONUS5770429
DESCRIPTIONUS5789215
EXAMINATIONUS6069010
OPPOSITIONEP1204740
OPPOSITIONEP1360287
OPPOSITIONEP1399575
OPPOSITIONEP2264163
OPPOSITIONEP2786657
OPPOSITIONEP2787075
OPPOSITIONEP3028564
OPPOSITIONUS2007280945
OPPOSITIONUS5789215
OPPOSITIONUS6114598
OPPOSITIONUS9012717
OPPOSITIONWO0236789
OPPOSITIONWO2008054606
OPPOSITIONWO2008076379
OPPOSITIONWO2009018411
OPPOSITIONWO2009023540
OPPOSITIONWO2015088643
OPPOSITIONWO2016081923
OPPOSITIONWO9100906
OPPOSITIONWO9945962
SEARCHUS5939598
SEARCHWO9945962

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents